* GW Pharmaceuticals initiates phase 3 pivotal study in tuberous sclerosis complex Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)
The post BRIEF-GW Pharmaceuticals initiates Phase 3 pivotal study in tuberous sclerosis complex appeared first on NASDAQ.